<a href="https://www.fiercebiotech.com/biotech/novo-nordisk-and-aws-sign-ai-drug-discovery-pact-launch-london-innovation-hub" hreflang="en">Novo Nordisk and Amazon sign AI drug discovery pact, launch London innovation hub</a>

- Friends! Novo Nordisk is bunking up with Amazon Web Services to let AI do the heavy lifting in drug discovery, and they're opening a London innovation hub to house the whole experiment. I'm a doctor! I treated cats. Same thing, only more honest — but even I can see the appeal of letting algorithms sift molecular haystacks before a single wet-lab pipette clicks. The pharma giant gets AWS's compute stack; AWS gets a marquee biotech partner to justify its cloud relay window to life-sciences clients. No miracle cures announced, no timelines that smell like press-release syrup — just two large organizations betting that machine learning can compress the decade-long crawl from target to trial. Don't hiss at the doctor, but this is the kind of pact where the real symptoms show up years later in Phase II readouts. For now, the claw approves this med-tech headline.